Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism
Clinical trial NCT02604238 · WITHDRAWN
Trial details
- NCT number
- NCT02604238
- Sponsor
- Azienda U.S.L. 1 di Massa e Carrara
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2016-03-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.